A complete application in a minute
Tailored resume and cover letter, ready to send.
CHDI Foundation is expanding its neuroimaging analytics capabilities to accelerate imaging biomarker development for Huntington’s disease. We seek a scientist skilled in MRI/PET data analytics, AI methods, and scalable data pipelines to advance biomarker discovery and cross-site harmonization.
The role involves designing reproducible pipelines, deploying AI-driven approaches, and collaborating with CHDI teams to drive biomarker strategies and data-driven insights.
Neuroimaging Analytics Specialist
Princeton, NJ- 2 days per week in office requirement.
Vice President, Clinical Neuroimaging Research
$115,000 – $145,000 Exact compensation will vary based on experience
Vaccination against COVID-19 is a prerequisite for employment at CHDI Management
CHDI Foundation, Inc. is a privately funded nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease (HD). CHDI has assembled a team of scientists and other professionals working in offices located in Los Angeles, New York City, and Princeton, NJ. Our scientists work closely with a network of more than 700 researchers in academic and industrial laboratories around the world in the pursuit of these novel therapies, providing strategic scientific direction to ensure that our common goals remain in focus.
CHDI works to increase the understanding of HD in order to hasten the development of therapeutic approaches. To achieve this goal, CHDI manages a diverse portfolio of research projects through a novel virtual model that encourages scientific collaboration, one which more directly connects academic research, drug discovery and clinical development. This helps bridge the translational gap that often exists between academic and industrial research pursuits and that adds costly delays to therapeutic development. In its role as a collaborative enabler, CHDI seeks to bring the right partners together to identify and address critical scientific issues and move drug candidates to clinical evaluation as rapidly as possible. Our activities extend from exploratory biology to the identification and validation of therapeutic targets, and from drug discovery and development to clinical studies and trials. More information about CHDI can be found at www.chdifoundation.org.
CHDI Foundation is expanding its neuroimaging analytics capabilities to accelerate the development of imaging biomarkers for Huntington’s disease (HD). We are seeking a highly motivated scientist with expertise in MRI and/or PET data analytics, quantitative image processing, and applied deep learning. This position will design and implement advanced data management pipelines, algorithm development, and artificial intelligence (AI) methods for structural and quantitative MRI, and PET imaging. The scientist will oversee data handling, algorithm development, and quantitative analysis across imaging modalities to establish analysis-ready datasets for integration into CHDI’s neuroimaging studies and biomarker development strategies. The successful candidate will build reproducible pipelines, and deploy novel and AI-driven approaches to improve biomarker discovery, harmonization, and predictive modeling across multi-site datasets.
CHDI Foundation is a private nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease (HD).
Our staff works for CHDI Management, Inc., which was established in 2002 to provide administrative and management services to CHDI Foundation, Inc.
CHDI’s activities focus solely on the collaborative development of therapeutics that will substantially improve the lives of those affected by Huntington’s disease. We are indebted to our donors, whose generosity and guidance have made possible this exclusive focus on science.